Synthetic peptide (Human) from an internal sequence.
- Extracts from COLO205 cells, A549 cells, human lung carcinoma tissue.
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS, 150mM Sodium chloride, pH 7.4
Concentration information loading...
Immunogen affinity purified
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/500 - 1/1000. Detects a band of approximately 74 kDa (predicted molecular weight: 74 kDa).
||1/500 - 1/1000.
||1/50 - 1/100.
Belongs to the FMR1 family.
Contains 2 KH domains.
Information by UniProt
- FMR1L2 antibody
- Fragile X mental retardation 1 like 2 antibody
- Fragile X mental retardation autosomal homolog 2 antibody
Immunocytochemistry/ Immunofluorescence - Anti-FXR2 antibody (ab65122)
This image shows A549 cells stained with ab65122 at 1/500-1/1000 dilution; with and without the immunising peptide.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FXR2 antibody (ab65122)
This image shows human lung carcinoma tissue stained with ab65122 at 1/50 - 1/100 dilution; with and without the immunising peptide.
Western blot - Anti-FXR2 antibody (ab65122)
All lanes : Anti-FXR2 antibody (ab65122) at 1/500 dilution
Lane 1 : extracts from COLO205 cells
Lane 2 : extracts from COLO205 cells with immunising peptide
Predicted band size: 74 kDa
Observed band size: 74 kDa
The amount of positive control loading for the WB is 5-30 ug of total protein. The amount of the peptide for the WB is 5-10 ug.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"